Style | Citing Format |
---|---|
MLA | Peimani M, et al.. "Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran." Journal of Diabetes and Metabolic Disorders, vol. 21, no. 1, 2022, pp. 61-68. |
APA | Peimani M, Bandarian F, Namazi N, Nasliesfahani E (2022). Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran. Journal of Diabetes and Metabolic Disorders, 21(1), 61-68. |
Chicago | Peimani M, Bandarian F, Namazi N, Nasliesfahani E. "Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran." Journal of Diabetes and Metabolic Disorders 21, no. 1 (2022): 61-68. |
Harvard | Peimani M et al. (2022) 'Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran', Journal of Diabetes and Metabolic Disorders, 21(1), pp. 61-68. |
Vancouver | Peimani M, Bandarian F, Namazi N, Nasliesfahani E. Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran. Journal of Diabetes and Metabolic Disorders. 2022;21(1):61-68. |
BibTex | @article{ author = {Peimani M and Bandarian F and Namazi N and Nasliesfahani E}, title = {Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {21}, number = {1}, pages = {61-68}, year = {2022} } |
RIS | TY - JOUR AU - Peimani M AU - Bandarian F AU - Namazi N AU - Nasliesfahani E TI - Covid-19-Specific Worries Among People With Type 2 Diabetes Following the Continuation of the Pandemic and Occurrence of Multiple Waves of Covid-19 in Iran JO - Journal of Diabetes and Metabolic Disorders VL - 21 IS - 1 SP - 61 EP - 68 PY - 2022 ER - |